Treatment could offer protective effect against kidney damage

   
   
Kidneys
28 Apr 2014 16:41:58.010
PA 114/14

Treating patients with a hormone or administering a simple medical procedure pre-operatively could help to prevent irreversible kidney damage commonly sustained during surgery, Nottingham researchers have found.

The team of academics from The University of Nottingham and clinicians at Nottingham University Hospitals NHS Trust have published evidence that the hormone erythropoietin (EPO) and the technique remote ischaemic preconditioning (RIPC) may offer a protective effect on the kidneys in a paper published in the journal American Journal of Physiology — Renal Physiology.

Dr David Gardner, in the University’s School of Veterinary Medicine and Science, led the research along with Dr Mark Devonald, a consultant in the hospital’s Renal and Transplant Unit.
Click here for full story

Important research findings

Dr Gardner said: “To date, animal models exploring the mechanisms of protection against kidney damage have largely been in laboratory rodents. To our knowledge, this is the first published research to investigate the potential effectiveness of EPO and RIPC in a large animal model — in this case a pig. This is important because the kidneys of a pig are very similar to those of a human and demonstrate similar responses, reducing the barrier to the translation of important research findings.”

Acute kidney injury (AKI) — previously known as acute renal failure — affects around 10 per cent of patients admitted to hospital and costs the NHS around £1 billion every year. Currently there is no effective treatment and only around 50 per cent of patients survive. Those who do survive often require long-term, regular kidney dialysis and in the most serious cases may be placed on the list for a kidney transplant.

One of the most common causes of kidney injury is ischaemia reperfusion (IR) where organ tissue is damaged when blood supply returns after a temporary lack of oxygen, for example during heart, vascular and other surgery or a trauma.

Reducing damage

Previous research has suggested there could be protective benefits by administering the hormone EPO which controls the production of red blood cells — but is better known as a performance enhancing drug — and the procedure RIPC, in which a blood pressure cuff is repeatedly inflated and deflated around an arm or leg to stimulate blood flow prior to surgery. However, scientists have previously been unable to uncover the mechanism by which these two protective methods appeared to work.

The Nottingham study has showed that both methods appeared to offer a protective effect, while EPO was the more effective out of the two in the short-term. Crucially, they have now outlined a mechanism by which the techniques may reduce the cellular damage which causes acute kidney injury.

The paper Remote Conditioning or Erythropoietin Before Surgery Primes Kidneys to Clear Ischemia-Reperfusion Damaged Cells — a Renoprotective Mechanism? is available on the journal’s website.

— Ends —

Our academics can now be interviewed for broadcast via our new Globelynx fixed camera facility at the University. For further information please contact a member of the Communications team on +44 (0)115 951 5798, email mediahub@nottingham.ac.uk or see the Globelynx website for how to register for this service.

For up to the minute media alerts follow us on Twitter

Notes to editors: The University of Nottinghamhas 43,000 students and is ‘the nearest Britain has to a truly global university, with campuses in China and Malaysia modelled on a headquarters that is among the most attractive in Britain’ (Times Good University Guide 2014). It is also the most popular university among graduate employers, the world’s greenest university, and winner of the Times Higher Education Award for ‘Outstanding Contribution to Sustainable Development’. It is ranked in the World's Top 75 universities by the QS World University Rankings.

Impact: The Nottingham Campaign, its biggest-ever fundraising campaign, is delivering the University’s vision to change lives, tackle global issues and shape the future. More news…



Story credits

More information is available from Dr David Gardner on +44 (0)115 951 6427, david.gardner@nottingham.ac.uk

Emma Thorne Emma Thorne - Media Relations Manager

Email: emma.thorne@nottingham.ac.uk Phone: +44 (0)115 951 5793 Location: University Park

Additional resources

No additional resources for this article

Related articles

Immune system link to kidney disease risk, research finds

Published Date
Wednesday 29th June 2016

MRI to offer advances in treatment for chronic kidney disease

Published Date
Monday 10th February 2014

Organ donation – do we opt-in or opt-out?

Published Date
Wednesday 24th September 2014

Media Relations - External Relations

The University of Nottingham
C Floor, Pope Building (Room C4)
University Park
Nottingham, NG7 2RD

telephone: +44 (0) 115 951 5798
email: communications@nottingham.ac.uk